Date | Time | Source | Headline | Symbol | Company |
07/29/2024 | 1:07PM | iHub Newswire | FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA | | |
07/23/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware | AMEX:MLSS | Milestone Scientific Inc |
07/18/2024 | 3:47PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:MLSS | Milestone Scientific Inc |
07/10/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Announces Favorable Medicare Pricing for its CompuFlo® Epidural System within First JMAC Region Covering Florida | AMEX:MLSS | Milestone Scientific Inc |
06/18/2024 | 11:00AM | GlobeNewswire Inc. | Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil | AMEX:MLSS | Milestone Scientific Inc |
06/05/2024 | 2:11PM | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | AMEX:MLSS | Milestone Scientific Inc |
05/16/2024 | 7:00AM | GlobeNewswire Inc. | Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024 | AMEX:MLSS | Milestone Scientific Inc |
05/15/2024 | 4:01PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:MLSS | Milestone Scientific Inc |
05/13/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call | AMEX:MLSS | Milestone Scientific Inc |
04/03/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida | AMEX:MLSS | Milestone Scientific Inc |
04/01/2024 | 7:00AM | GlobeNewswire Inc. | Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023 | AMEX:MLSS | Milestone Scientific Inc |
03/28/2024 | 11:45AM | GlobeNewswire Inc. | Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call | AMEX:MLSS | Milestone Scientific Inc |
03/14/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians | AMEX:MLSS | Milestone Scientific Inc |
02/28/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio | AMEX:MLSS | Milestone Scientific Inc |
02/20/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast | AMEX:MLSS | Milestone Scientific Inc |
01/16/2024 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update | AMEX:MLSS | Milestone Scientific Inc |
01/12/2024 | 4:34PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:MLSS | Milestone Scientific Inc |
12/13/2023 | 5:00PM | GlobeNewswire Inc. | Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock | AMEX:MLSS | Milestone Scientific Inc |
12/13/2023 | 12:01PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:MLSS | Milestone Scientific Inc |
12/12/2023 | 5:21PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:MLSS | Milestone Scientific Inc |
12/12/2023 | 5:10PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | AMEX:MLSS | Milestone Scientific Inc |
12/10/2023 | 8:33PM | GlobeNewswire Inc. | Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock | AMEX:MLSS | Milestone Scientific Inc |
12/08/2023 | 4:03PM | GlobeNewswire Inc. | Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock | AMEX:MLSS | Milestone Scientific Inc |
12/08/2023 | 4:00PM | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | AMEX:MLSS | Milestone Scientific Inc |
12/08/2023 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation Procedures | AMEX:MLSS | Milestone Scientific Inc |
11/28/2023 | 8:30AM | GlobeNewswire Inc. | Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across Spain | AMEX:MLSS | Milestone Scientific Inc |
11/15/2023 | 7:00AM | GlobeNewswire Inc. | Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023 | AMEX:MLSS | Milestone Scientific Inc |
11/10/2023 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call | AMEX:MLSS | Milestone Scientific Inc |
11/09/2023 | 8:30AM | GlobeNewswire Inc. | Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New York | AMEX:MLSS | Milestone Scientific Inc |
10/31/2023 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | AMEX:MLSS | Milestone Scientific Inc |